SEC Form 4 · accession 0001179110-15-012447
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Ellberger
Director
Period of report
Aug 20, 2015
Accepted (ET)
Aug 21, 2015 · 7:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | Aug 20, 2015 | P | 5,000 | $15.00 | A | 48,500 | D |
Table II — derivative securities
No Table II lines on this filing.